周脑下关节出血的体积测定
Emily Hoffmann1, Hermann Krähling2, Moritz Kleinevoss1
1Clinic of Radiology, University of Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
Neurology and therapy
|August 22, 2025
概括
体积CT生物标志物不能预测周脑下关节出血 (pmSAH) 的结果. 与动脉瘤SAH不同,这些标志物与pmSAH患者的并发症或功能恢复没有相关性.
科学领域:
- 神经辐射学
- 神经临床护理
- 医学成像分析
背景情况:
- 周脑下关节出血 (pmSAH) 是一种罕见的,典型的良性非动脉瘤下关节出血 (SAH).
- 虽然pmSAH通常有利,但可能导致血管,脑水和延迟脑缺血 (DCI) 等并发症.
- 目前pmSAH的风险分层方法缺乏可靠的成像生物标志物.
研究的目的:
- 在pmSAH患者中评估基于CT的体积生物标志物的预测值.
- 确定在动脉瘤SAH (aSAH) 中验证的生物标志物是否也适用于pmSAH.
- 评估体积参数与临床表现,并发症和功能结果之间的关联.
主要方法:
- 72名pmSAH患者的回顾性分析 (2011-2024年).
- 使用3D切片器和TotalSegmentator进行自动体积细分,以量化内体积 (ICV),大脑体积 (BV),脑脊液 (CSF) 和选择性体积 (SSV).
- 用于评估与临床数据和结果的非参数统计和斯皮尔曼相关性 (格拉斯哥结果尺度,GOS).
主要成果:
- 平均体积测量:ICV为1352.7毫升,BV为1247.3毫升,CSF为95.9毫升,SSV为19.4毫升
- 吐与CSF和SSV的增加有关 (p=0. 04, p=0. 005).
- 没有发现其他症状或并发症 (血管,水脑,DCI) 的显著体积差异. GOS分数高 (中位数=5),与体积标记没有显著的相关性.
结论:
- 与aSAH不同的是,体积CT生物标志物 (ICV,BV,CSF,SSV) 在pmSAH中缺乏预测价值.
- 对pmSAH的风险分层应依赖于初始出血特征,临床监测和个性化评估.
- 进一步的研究可能会探索pmSAH风险分层的其他成像方法或临床因素.
相关概念视频
Hemorrhagic Stroke l: Introduction
20
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
20
Hemorrhagic Stroke ll: Pathophysiology
30
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
30


